In studies of Hepatocellular Carcinoma (HCC), SUMOylation enhances the ability of NRF2 to scavenge ROS and upregulate PHGDH, promoting de novo serine synthesis. This evidence concerns the gene PHGDH and hepatocellular carcinoma.